Abstract:Cleidocranial dysplasia (CCD) is a rare autosomal dominant disorder caused by mutations in the Runx2 gene. The CCD is characterized by frontal bossing, a patent anterior fontanelle, presence of Wormian bones, midface hypoplasia, multiple dental abnormalities, clavicular hypoplasia or aplasia, skeletal abnormalities, and short stature. The aims of this study are to report the phenotypic manifestations of all patients who presented with CCD and to review the multidisciplinary management of these patients. The longitudinal data of patients with a diagnosis of CCD treated at The Australian Craniofacial Unit from 1980 to 2019 were reviewed. Fourteen patients were identified for inclusion in this study. The age at referral to the unit ranged from 1 week old to 49 years old (mean 11.2 years old). All patients had clinical features of frontal bossing, a patent anterior fontanelle, multiple Wormian bones, midface hypoplasia, abnormal dentition, clavicular hypoplasia/aplasia, and normal intellect. Eleven patients had obstructive sleep apnea. Eight patients had positive family history. Speech issues were found in 6 patients and abnormal hearing was found in 4 patients. Seven patients who underwent skeletal survey were found to have skeletal abnormalities. All patients were evaluated and managed by the multidisciplinary team, which consisted of craniofacial surgeons, pediatric dentists, orthodontists, ENT surgeons, pediatricians, clinical geneticists, radiologists, orthopedic surgeons, and social workers. All patients were treated by dentists/orthodontists requiring multiple surgical interventions and orthodontic treatment. Seven patients who had recurrent ear infection underwent ventilation tube insertion. Seven of 11 patients who had obstructive sleep apnea underwent adenotonsillectomy. Four patients underwent orthognathic surgery to correct midface hypoplasia and malocclusion. Two patients had cranioplasty for correction of metopic depressions. The characteristic findings of patients with CCD involving multiple regions of the body should draw clinicians' attention to the need for multidisciplinary management of these patients.

A Case of Cleidocranial Dysplasia with a Novel Mutation and Growth Velocity Gain with Growth Hormone Treatment

Clinical Spectrum of Cleidocranial Dysplasia in a Family with Twins

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

Combined Orthodontic-Surgical Sequential Treatment of Cleidocranial Dysplasia

Clinical Features and Diagnosis of Cleidocranial Dysplasia

Cleidocranial dysplasia with growth hormone deficiency: a case report

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

Mutation Analysis of the RUNX2 Gene in a Family with Cleidocranial Dysplasia

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

Cleidocranial dysplasia: a case report

Cleidocranial dysplasia: Clinical, endocrinologic and molecular findings in 15 patients from 11 families

[Cleidocranial Dysplasia: Two Cases Report and Signature Analysis].

Skeletal and molecular findings in 51 Cleidocranial dysplasia patients from Turkey

Cleidocranial Dysplasia Presenting With Mixed Dentition in a 28-Year-Old Male: A Case Report

Cleidocranial Dysplasia: Report of 3 Cases and Literature Review

Cleidocranial Dysplasia: A Clinico-radiographic Spectrum with Differential Diagnosis

Molecular Genetics of Cleidocranial Dysplasia

Cleidocranial Dysplasia: Management of the Multiple Craniofacial and Skeletal Anomalies

Rare Findings in Cleidocranial Dysplasia Caused by RUNX Mutation

Cleidocranial dysplasia: oral features and genetic analysis of 11 patients

Complex Dental Anomalies in A Belatedly Diagnosed Cleidocranial Dysplasia Patient